During the past decade, Cancer Care Associates - Mercy Campus conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 13 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 4 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Cancer Care Associates - Mercy Campus" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 12 trials, followed by "ECOG-ACRIN Cancer Research Group" with 3 trials sponsored, "NSABP Foundation Inc" with 3 trials sponsored, "SWOG Cancer Research Network" with 2 trials sponsored and "Eisai Inc." with 2 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cancer Care Associates - Mercy Campus" #1 collaborator was "National Cancer Institute (NCI)" with 21 trials as a collaborator, "NCIC Clinical Trials Group" with 3 trials as a collaborator, "Bristol-Myers Squibb" with 2 trials as a collaborator, "SWOG Cancer Research Network" with 2 trials as a collaborator and "Aptuit" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Cancer Care Associates - Mercy Campus" are "Breast Cancer" (9 trials), "Lung Cancer" (3 trials), "Colorectal Cancer" (2 trials), "Melanoma (Skin)" (2 trials) and "Acute Leukemia" (1 trials). Many other conditions were trialed in "Cancer Care Associates - Mercy Campus" in a lesser frequency.

Most popular intervention types in "Cancer Care Associates - Mercy Campus" are "Drug" (18 trials), "Biological" (8 trials), "Other" (7 trials), "Radiation" (2 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "placebo" (5 trials), "bevacizumab" (3 trials), "cyclophosphamide" (3 trials), "paclitaxel" (3 trials) and "AC regimen" (2 trials). Other intervention names were less common.

The vast majority of trials in "Cancer Care Associates - Mercy Campus" are 16 trials for "All" genders and 6 trials for "Female" genders.

Currently, there are NaN active trials in "Cancer Care Associates - Mercy Campus". undefined are not yet recruiting, undefined are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in Cancer Care Associates - Mercy Campus, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Cancer Care Associates - Mercy Campus, 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".